Skip to Main Content

Paper Details

PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Gynecol Oncol
48
2019
Author NameAffiliation
Fr??d??ric AmantUniversity of Leuven, Netherlands Cancer Institute and Amsterdam Medical Centres
Catherine J KennedyThe Westmead Institute for Medical Research, The University of Sydney, Westmead Hospital
Anna DeFazioThe Westmead Institute for Medical Research, The University of Sydney, Westmead Hospital
Anna DeFazioThe Westmead Institute for Medical Research, The University of Sydney, Westmead Hospital
  • 1 - 4

Datasets

Release 1.2